These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sex differences in choline-deficient diet-induced steatohepatitis in mice. Kashireddy PR, Rao MS. Exp Biol Med (Maywood); 2004 Feb; 229(2):158-62. PubMed ID: 14734794 [Abstract] [Full Text] [Related]
3. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994 [Abstract] [Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation. Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC. J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330 [Abstract] [Full Text] [Related]
5. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model. Tzeng TF, Tzeng YC, Cheng YJ, Liou SS, Liu IM. Nutrients; 2015 Oct 21; 7(10):8670-84. PubMed ID: 26506376 [Abstract] [Full Text] [Related]
6. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM. Food Chem Toxicol; 2014 Feb 21; 64():94-103. PubMed ID: 24275089 [Abstract] [Full Text] [Related]
7. Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α. Chen T, Shi D, Chen J, Yang Y, Qiu M, Wang W, Qiu L. Mol Med Rep; 2015 Jan 21; 11(1):303-8. PubMed ID: 25333350 [Abstract] [Full Text] [Related]
8. Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis. Macfarlane DP, Zou X, Andrew R, Morton NM, Livingstone DE, Aucott RL, Nyirenda MJ, Iredale JP, Walker BR. Am J Physiol Endocrinol Metab; 2011 Feb 21; 300(2):E402-9. PubMed ID: 21119028 [Abstract] [Full Text] [Related]
9. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis. Rivera CA, Gaskin L, Allman M, Pang J, Brady K, Adegboyega P, Pruitt K. BMC Gastroenterol; 2010 May 28; 10():52. PubMed ID: 20509914 [Abstract] [Full Text] [Related]
10. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N. Metabolism; 2013 Nov 28; 62(11):1651-61. PubMed ID: 23928105 [Abstract] [Full Text] [Related]
11. PPARα protects against trans-fatty-acid-containing diet-induced steatohepatitis. Hu X, Tanaka N, Guo R, Lu Y, Nakajima T, Gonzalez FJ, Aoyama T. J Nutr Biochem; 2017 Jan 28; 39():77-85. PubMed ID: 27816763 [Abstract] [Full Text] [Related]
12. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis. Okada K, Warabi E, Sugimoto H, Horie M, Tokushige K, Ueda T, Harada N, Taguchi K, Hashimoto E, Itoh K, Ishii T, Utsunomiya H, Yamamoto M, Shoda J. J Gastroenterol; 2012 Aug 28; 47(8):924-35. PubMed ID: 22367278 [Abstract] [Full Text] [Related]
13. Myeloid- and hepatocyte-specific deletion of group VIA calcium-independent phospholipase A2 leads to dichotomous opposing phenotypes during MCD diet-induced NASH. Jansakun C, Chunglok W, Altamura S, Muckenthaler M, Staffer S, Tuma-Kellner S, Merle U, Chamulitrat W. Biochim Biophys Acta Mol Basis Dis; 2023 Jan 01; 1869(1):166590. PubMed ID: 36334837 [Abstract] [Full Text] [Related]
14. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet. Romestaing C, Piquet MA, Letexier D, Rey B, Mourier A, Servais S, Belouze M, Rouleau V, Dautresme M, Ollivier I, Favier R, Rigoulet M, Duchamp C, Sibille B. Am J Physiol Endocrinol Metab; 2008 Jan 01; 294(1):E110-9. PubMed ID: 17986629 [Abstract] [Full Text] [Related]
15. Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice. Park HS, Jang JE, Ko MS, Woo SH, Kim BJ, Kim HS, Park HS, Park IS, Koh EH, Lee KU. Diabetes Metab J; 2016 Oct 01; 40(5):376-385. PubMed ID: 27098507 [Abstract] [Full Text] [Related]
16. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. Chen T, Zhong FJ, Hong YM, Su WJ, Zhuang LL, Qiu LX. Chin J Nat Med; 2014 Mar 01; 12(3):194-8. PubMed ID: 24702805 [Abstract] [Full Text] [Related]
17. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Mu YP, Ogawa T, Kawada N. Lab Invest; 2010 Feb 01; 90(2):245-56. PubMed ID: 19949375 [Abstract] [Full Text] [Related]
19. Effects of probiotics on methionine choline deficient diet-induced steatohepatitis in rats. Karahan N, Işler M, Koyu A, Karahan AG, Başyığıt Kiliç G, Cırış IM, Sütçü R, Onaran I, Cam H, Keskın M. Turk J Gastroenterol; 2012 Apr 01; 23(2):110-21. PubMed ID: 22706738 [Abstract] [Full Text] [Related]
20. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Loyer X, Paradis V, Hénique C, Vion AC, Colnot N, Guerin CL, Devue C, On S, Scetbun J, Romain M, Paul JL, Rothenberg ME, Marcellin P, Durand F, Bedossa P, Prip-Buus C, Baugé E, Staels B, Boulanger CM, Tedgui A, Rautou PE. Gut; 2016 Nov 01; 65(11):1882-1894. PubMed ID: 26338827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]